Skip to main content
Top

Journal of Hematology & Oncology

Issue Special Issue 1/2009

Current trends in leukemia, lymphoma, myeloma and ITP: updates and highlights from ASH 2008

Content (6 Articles)

Open Access Meeting abstract

Update of recent studies in chronic myeloid leukemia

Karen Seiter

Open Access Meeting abstract

New insights on low-grade and T-cell lymphoma

William Tse

Open Access Meeting abstract

Update on chronic immune thrombocytopenic purpura (ITP)

Robert McMillan

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine